457 News Items found
MSK physician-scientist Charles Sawyers and SKI computational biologist Dana Pe’er
MSK Researchers Discover How Cancer Cells Change Identity To Escape Therapies
Researchers learn how prostate cancer cells change their type to survive treatment.
In the Lab
Scott Lowe
SKI Scientists Solve 30-Year-Old Mystery About p53 Protein — Dubbed ‘Guardian of the Genome’
Rather than promoting genetic chaos, loss of p53 leads to an orderly progression of genetic changes that no one saw coming.
SKI molecular biologist John Maciejowski
SKI Study Sheds Light on How a Natural Defense Against Viruses Can Lead to Mutations in Cancer Cells
A protein in the body that protects against viruses can also cause cancer-related mutations.
MSK pathologist Natasha Rekhtman and physician-scientist Charles Rudin
MSK Scientists Identify Rare (Rb-Proficient) Subtype of Small Cell Lung Cancer
Unlike most small cell lung cancer tumors, these retain a normal copy of a protein called RB.
MSK molecular geneticist Elli Papaemmanuil
Improved Scoring System for Myelodysplastic Syndromes Could Help Doctors Tailor Treatment
The revised scoring system incorporates molecular information related to 31 genes to help predict risk.
Side-by-side headshots of scientists Christopher Lima and Rhyan Puno
With Cryo-EM, SKI Scientists Determine Structure of Key Factor in RNA Quality Control
Called NEXT, the factor plays an important role in handing over RNA to the exosome for destruction.
MSK physician-scientist Yu Chen
MSK Scientists Identify New — and Very Common — Subtype of Prostate Cancer
The findings could pave the way toward more targeted treatments for the disease.
GSK dean and graduates in their caps and gowns
MSK’s 2022 Convocation and Commencement Ceremony Recognizes Graduates and Award Winners
At Memorial Sloan Kettering Cancer Center’s 43rd annual event recognizing graduates and award winners, honorees were welcomed back to an in-person event.
Dan Heller
A Sensor Sniffs for Cancer, Using Artificial Intelligence
By detecting molecular signatures in the blood, the sensor may help improve cancer screenings.
SKI immunologist Ming Li
SKI Scientists Identify Potential New ‘Soldier’ for Cancer Immunotherapy
The new cells, which the scientists have dubbed killer innate-like T cells, differ in several notable ways from the conventional target of many immunotherapies.